[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 1, Issue 2 (12-2023) ::
Health Res Develop 2023, 1(2): 73-84 Back to browse issues page
Challenges of the intellectual property system in pharmaceutical innovations resulting from artificial intelligence
Shahriar Eslamitabar1 , Babak Sabet2 , Ehsan Lame * 3
1- SMUMS, dreslamitabar@yahoo.com
2- Shahis Beheshti, sabetdivshali@gmail.com
3- Azad University, ehsanlame@yahoo.com , ehsanlame@gmail.com
Abstract:   (348 Views)
The patent system has long been criticized for limiting access to medicines. Dramatic advances in artificial intelligence and machine learning technology present a revolutionary opportunity in drug discovery, formulation and testing of dosage forms. The pharmaceutical industry claims that patenting is necessary to encourage innovation in the risky, lengthy, and costly research and development (R&D) process. But it still does not provide logical evidence about the actual effects of patents on innovation. The increasing use of artificial intelligence in research is intensifying the debate about pharmaceutical patents. Inventions created or enabled by artificial intelligence raise questions about patentability and patent policy in general. Faster and more efficient research and development weakens the justification for pharmaceutical patents. Research findings suggest that despite the necessity of continuing incentives for drug research and development, lawmakers should consider alternative systems that prioritize access alongside incentives to advance healthcare as a human right.
 
Keywords: artificial intelligence, drug, patent, invention
Full-Text [PDF 740 kb]   (181 Downloads)    
Type of Study: Original | Subject: Special
Received: 2024/01/20 | Accepted: 2023/12/31 | Published: 2023/12/31
References
1. Habibzadeh, Taher, Artificial intelligence and its legal issues: from its emergence until now, 2019
2. 5.Canales Jordi, Hucamp Franz, The Future of Management in the World of Artificial Intelligence, translated by A. Adib, Parse Publications 1401
3. Pagua, Ugo, Robot Laws (Crimes, Contracts and Responsibilities), translated by Dr. Peyman Namamian, Mizan Legal Foundation, 2019
4. Islami Tabar Shahriar, Lam Ehsan, Alizadeh Malik Saeed, Anwar Fatemeh. Intellectual property rights and research and development challenges in the pharmaceutical industry. Halal Research Journal 1400;4(1):58-684. Fei Jiang et al., Artificial Intelligence in Healthcare: Past, Present and Future, 2 STROKE& VASCULAR NEUROLOGY 230, 230-31 (2017) [DOI:10.1136/svn-2017-000101] [PMID] []
5. . H.C. Stephen Chan et al., Advancing Drug Discovery via Artificial Intelligence, 40 TRENDS IN PHARMACOLOGICAL SCI. 592, 592-604 (2019) [DOI:10.1016/j.tips.2019.06.004] [PMID]
6. 10. Chris Wood, Machine-Learning Robot Could Streamline Drug Development, NEW ATLAS (, 2016), http://newatlas.com/machine-learning-drug-development/41759/ [https: //perma.cc / 6ELEEQFJ]
7. 2. Pedram Ebrahimnejad et al., Applications of Artificial Intelligence in Pharmacy Education: Legal and Ethical Challenges, Journal of Mazandaran University of Medical Sciences, Volume 33, Number 227, Year 1402, p. 177
8. .Cockburn I.M. Intellectual Property Rights and Pharmaceuticals: Challenges And Opportunities For Economic Research. 1995,
9. Jane Wakefield, Artificial Intelligence-Created Medicine to be Used on Humans for First Time,BBC (Jan. 30, 2020), https://www.bbc.com/news/technology-51315462 [https://perma.cc/GFP6-MJJP].
10. Islami Tabar Shahriar, Lam Ehsan, Alizadeh Malik Saeed, Anwar Fatemeh. Intellectual property rights and research and development challenges in the pharmaceutical industry. Halal Research Journal 1400;4(1):58-684. Fei Jiang et al., Artificial Intelligence in Healthcare: Past, Present and Future, 2 STROKE& VASCULAR NEUROLOGY 230, 230-31 (2017) [DOI:10.1136/svn-2017-000101] [PMID] []
11. Zahedi Madi, Erfan Manesh Mohammad Hossein, Patentability of Pharmaceutical Dosage Regimens in Europe, Private Law Research Journal, Allameh Tabatabaie University
12. World Intellectual Property Organization (2003) What is Intellectual Property? In: WIPO Pub. No. 450
13. Afrasiab, Mehboob, Industrial Property in Iran's Legal System with Emphasis on "Trademark, Industrial Design, Invention" Jurisdiction, Science and Science Publications, 1400
14. Afrasiab, Mehboob, Industrial Property in Iran's Legal System with Emphasis on "Trademark, Industrial Design, Invention" Jurisdiction, Science and Science Publications, 2021
15. Afrasiab, Mehboob, Industrial Property in Iran's Legal System with Emphasis on "Trademark, Industrial Design, Invention" Jurisdiction, Science and Science Publications, 2021
16. World Intellectual Property Organization (2003) What is Intellectual Property? In: WIPO Pub. No. 450
17. 8. Lalitkumar K. Vora , Amol D. Gholap et al, Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design,
18. Shafiei, Mozhgan, Investigating the impact of artificial intelligence on health businesses, Journal of Entrepreneurship Research, 2021, No. 1, p. 34
19. Kay Firth-Butterfield & Yoon chaf, World Econ. F., artificial intelligence Collides with patents law 8-9 (2018),
20. Ryan Abbott, I Think, Therefore I Invent: Creative Computers and the Future of Patent Law, 57B.C. L. REV. 1079, 1093-94 (2016). [DOI:10.2139/ssrn.2727884]
21. Pagua, Ugo, Robot Laws (Crimes, Contracts and Responsibilities), translated by Dr. Peyman Namamian, Mizan Legal Foundation, 2019
22. Ryan Abbott, I Think, Therefore I Invent: Creative Computers and the Future of Patent Law, 57B.C. L. REV. 1079, 1093-94 (2016. [DOI:10.2139/ssrn.2727884]
23. Ryan Abbott, I Think, Therefore I Invent: Creative Computers and the Future of Patent Law, 57B.C. L. REV. 1079, 1093-94 (2016). [DOI:10.2139/ssrn.2727884]
24. Magnusson Sjöberg C (2018) The Swedish administrative procedure act and digitalisation, in 50 years of law and IT. In: Wahlgren P (ed) Scandinavian studies in law, vol 65. The Swedish Law and Informatics Research Institute 1968-2018, Stockholm. Institute for Scandinavian Law, Stockholm
25. András Hárs(2022), AI and international law - Legal personality and avenues for regulation, Hungarian Journal of Legal Studies, Volume 62: Issue 4 [DOI:10.1556/2052.2022.00352]
26. András Hárs(2022), AI and international law - Legal personality and avenues for regulation, Hungarian Journal of Legal Studies, Volume 62: Issue 4 [DOI:10.1556/2052.2022.00352]
27. Von der Lieth GA (1987) An artificial intelligence approach to legal reasoning. Massachusetts Institute of Technology, Cambridge
28. Wahlgren P (2018) In report Livet med AI (SSF-rapport nr 29) published by S23elsen för strategisk forskning. pp. 52-57
29. F.M. Scherer, The Pharmaceutical Industry-Prices and Progress, 351 NEW ENG. J. MED. 927,927 (2004) [DOI:10.1056/NEJMhpr040117] [PMID]
30. Habibzadeh, Taher, Artificial intelligence and its legal issues: from its emergence until now, 2019
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

eslamitabar S, Sabet B, Lame E. (2023). Challenges of the intellectual property system in pharmaceutical innovations resulting from artificial intelligence. Health Res Develop. 1(2), 73-84. doi:10.61186/jhrd.1.2.73
URL: http://jhrd.trjums.ac.ir/article-1-43-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 1, Issue 2 (12-2023) Back to browse issues page
پژوهش و توسعه سلامت Health research and development
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4660